Glucometer Market Report 2026

Glucometer Market Overview

• Glucometer market size has reached to $15.43 billion in 2025 • Expected to grow to $26.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.6% • Growth Driver: Rising Diabetes Prevalence Drives Growth In The Glucometer Market • Market Trend: Advancing Diabetes Management through Smart Connectivity • North America was the largest region in 2025.

What Is Covered Under Glucometer Market?

A glucometer, also referred to as a glucose meter is a medical instrument for estimating the level of glucose in the blood. This compact portable instrument measures the quantity of glucose in the blood also known as the blood glucose level. This is a common tool used by people with diabetes to help them control their disease. The main types of glucometers are continuous glucose monitoring devices and self-monitoring blood glucose systems. Continuous glucose monitoring devices are medical devices that are automatically monitored by continuous glucose monitoring both throughout the day and at night. The various techniques are invasive and non-invasive that are distributed through institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies and online pharmacies.

What Is The Glucometer Market Growth Forecast?

The glucometer market size is expected to see rapid growth in the next few years. It will grow to $26.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled glucose monitoring, rising demand for wearable health devices, expansion of digital diabetes management platforms, growing focus on personalized diabetes care, increasing integration with telehealth services. Major trends in the forecast period include increasing adoption of continuous glucose monitoring systems, rising demand for non-invasive glucose monitoring, growing integration of mobile health applications, expansion of home-based diabetes monitoring solutions, enhanced focus on real-time data analytics.

Global Glucometer Market Segmentation

1) By Product: Continuous Glucose Monitoring Devices, Self-Monitoring Blood Glucose System 2) By Technique: Invasive, Non-Invasive 3) By Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Continuous Glucose Monitoring Devices: Real-Time CGM Systems, Flash Glucose Monitoring Systems 2) By Self-Monitoring Blood Glucose System: Blood Glucose Meters, Test Strips, Lancets

What Is The Driver Of The Glucometer Market?

The increase in the prevalence of diabetes is driving the demand for the glucometer market going forward. Diabetes is a long-lasting metabolic condition. It is characterized by high blood glucose (also known as blood sugar) levels, which, over time, cause significant harm to the heart, blood vessels, eyes, kidneys, and nerves. People who are suffering from diabetes use a glucometer to monitor their blood glucose levels. Therefore, with an increase in diabetes among people, the demand for glucometers is also increasing. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022. Therefore, the increase in the prevalence of diabetes drives the glucometer industry.

Key Players In The Global Glucometer Market

Major companies operating in the glucometer market are Johnson & Johnson Services Inc., Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic plc., Arkray Inc., Omron Corporation, Dexcom Inc., Bionime Corporation, LifeScan Inc., NOVA Biomedical, Sinocare Inc., TaiDoc Technology Corporation, i-SENS Inc., EKF Diagnostics Holdings plc, ForaCare Inc., LabStyle Innovations Corp., Acon Laboratories Inc., Ascensia Diabetes Care Holdings AG, Ypsomed AG, Medtrum Health Inc., Cellnovo Group

Global Glucometer Market Trends and Insights

Major companies operating in the glucometer market are focused on developing built-in cellular technology to enhance real-time data transmission and remote monitoring capabilities. Built-in cellular technology is the integration of cellular communication capabilities directly into a device, allowing it to connect to mobile networks without needing a separate module or external device. For instance, in May 2024, Smart Meter, a US-based monitoring device company, launched iGlucose Plus for enhanced diabetes management. This technology enables devices to send and receive data via cellular networks, similar to how smartphones operate, thereby facilitating timely access to health information, improving patient engagement, and allowing healthcare providers to monitor and manage patients' glucose levels more effectively, ultimately leading to better health outcomes and more personalized care.

What Are Latest Mergers And Acquisitions In The Glucometer Market?

In August 2024, MTD Group, an Italy-based provider of consumer health products, acquired Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems for an undisclosed amount. Through this acquisition, MTD aims to reinforce its global presence in diabetes care by expanding its production capacity, advancing its technological capabilities, and entering high-growth markets such as China and India. Ypsomed is a Switzerland-based company that offers pen needles and blood glucose monitoring systems designed to support both self-care and professional diabetes management.

Regional Outlook

North America was the largest region in the glucometer market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Glucometer Market?

The glucometer market consists of the sale of testing strips, lancing pens, lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.